The margin illusion
Med spa revenue looks impressive. A busy practice can bring in $2-3M per year with a relatively small footprint. The per-treatment revenue numbers are high. A single syringe of filler at $700. A laser treatment at $1,200. A body contouring session at $2,500.
But the margins are not what most owners think they are.
The average med spa operates at a 20-25% net margin. That means on $2M in revenue, the owner takes home $400,000-$500,000. That sounds reasonable until you realize that top-performing med spas hit 35-40% margins. The gap between average and top is $200,000-$300,000 per year on the same revenue.
Where does the difference go? Into costs that most owners either underestimate, do not track, or accept as fixed when they are actually controllable.
Where the money goes
Injectable cost of goods: 30-40% of treatment revenue
This is the biggest single cost in most med spas, and it is the one with the most variability.
Your cost for a syringe of hyaluronic acid filler is somewhere between $200 and $350 depending on the brand, your purchasing volume, and your relationship with the distributor. If you sell that syringe at $700, your cost of goods is 29-50% of the treatment revenue on that single service.
Botox and other neurotoxins run differently. Your cost per unit is roughly $5-6, and you charge $12-15 per unit. On a 40-unit treatment, your cost is $200-$240 against revenue of $480-$600. That is a better margin, but it is also a lower-ticket service.
When I look at a med spa's overall injectable COGS, I want to see it at or below 35% of injectable revenue. Above 40%, something is wrong. Either pricing is too low, the product mix skews toward expensive fillers without adequate markup, or there is waste.
The waste problem is real and often invisible. A syringe gets opened and only partially used. The remainder is discarded because the practice cannot legally use it on another patient. A vial of neurotoxin is reconstituted and not fully used within the recommended timeframe. Product expires on the shelf because it was over-ordered.
One med spa I reviewed (anonymized Sorso client, suburban Midwest, single location ~$1.4M revenue) was spending $42,000 per month on injectables against $105,000 in injectable revenue. That is 40%. When we dug into it, $3,200 per month was waste from partially used syringes and expired product. Reducing that waste through better scheduling (batching similar treatments) and inventory management brought COGS down to 36%. That $4,200 monthly savings is $50,400 per year.
Equipment leases: the cost that locks you in
A single laser device can cost $80,000-$250,000. Most med spas do not buy outright. They lease. A typical lease runs $2,000-$5,000 per month per device over 3-5 years.
A med spa with three or four devices can easily be paying $10,000-$15,000 per month in equipment leases. That is $120,000-$180,000 per year before you treat a single patient with those machines.
The problem is not the lease itself. It is the utilization rate. If a laser that costs you $4,000 per month generates $20,000 in treatment revenue, the economics work. If it generates $6,000 because demand for that particular treatment dropped or a newer technology made it less popular, you are underwater on that device but still locked into the lease.
I see this constantly. A med spa bought a body contouring device in 2023. Demand was strong for a year. Then a competitor got a newer model. Patient volume on that device dropped by half. The lease still has two years left. The owner is paying $3,500 per month for a machine that generates $4,200 in revenue, against which you still need to pay consumables, staff time, and marketing. The real margin on that device is close to zero.
Before signing any equipment lease, model the break-even. How many treatments per month do you need at your current pricing to cover the lease plus consumables plus the allocated staff time? What happens if volume drops 30%? What happens if you need to cut prices to compete?
Marketing: 8-15% of revenue
Med spas spend more on marketing than almost any other healthcare specialty. The reason is straightforward: most med spa services are elective. Patients do not get referred by a primary care physician. They find you through Instagram, Google, word of mouth, or an influencer.
For most healthcare practices, marketing spend of 3-5% of revenue is typical. For med spas, the picture is different: AmSpa's 2024 State of the Industry Report pegs the average at around 7% of revenue, but growth-oriented and newer practices routinely run 8-12% or higher, and industry experts recommend 8-15% for practices actively pushing for growth.
On a $2M practice, 10% is $200,000 per year in marketing spend. That covers social media management, paid ads (Google and Meta), content creation, a website, email campaigns, and probably an agency fee or two.
The question is not whether you should spend on marketing. You should. The question is whether you know which channels produce profitable patients.
I worked with a med spa (anonymized Sorso client, South Florida, single location ~$2M revenue) that was spending $18,000 per month across Google Ads, Meta Ads, and influencer partnerships. When we tracked patient acquisition by channel and then tracked those patients' lifetime value over 12 months, the results were not what the owner expected.
Google Ads produced patients with an average first-visit spend of $850 and a 40% rebooking rate. Meta Ads produced patients with an average first-visit spend of $420 and a 25% rebooking rate. The influencer partnerships produced a lot of followers but very few paying patients.
The cost per acquisition from Google was $185. From Meta, it was $140. From influencers, it was $620 when you divided the partnership costs by actual patients who booked and showed up.
Once we had that data, the decision was simple. Shift budget from influencer partnerships to Google Ads. The total marketing spend stayed the same, but the return improved by about $4,500 per month.
Most med spas cannot produce this analysis because they do not track where patients come from with enough precision. If you are spending $200,000+ per year on marketing and you cannot tell me the cost per acquisition and 12-month value by channel, you are flying blind.
Staff costs: the hidden complexity
A med spa's staffing model is more complex than a typical medical practice. You have clinical staff (nurse practitioners, physician assistants, RNs, estheticians), front desk and patient coordinators, and potentially a medical director who may or may not be on site.
Clinical staff compensation varies widely. Nurse injectors command $80,000-$120,000 in base salary plus bonuses or commissions on product sales. Estheticians run $45,000-$65,000. A medical director who provides oversight but does not treat patients might cost $2,000-$5,000 per month.
The commission structures add complexity. Some practices pay injectors 15-25% of the revenue they generate. Others pay flat salaries. Some do hybrid models. The right model depends on your revenue mix and how much provider autonomy you want, but you need to model the economics of each provider the same way a dental practice needs to model each operatory.
I reviewed a med spa (anonymized Sorso client, Texas, two locations) where one nurse injector generated $45,000 per month in revenue and was paid $9,500 (base plus commission). Another generated $22,000 per month and was paid $8,200. Same commission structure, same hours. The first injector was highly profitable. The second was barely covering their cost after you allocated room, supplies, and overhead. The owner did not know this because total staff costs were tracked in aggregate, not per provider.
Rent: location is expensive
Med spas tend to be in high-visibility retail or commercial locations. You are competing for the same real estate as boutique fitness studios and high-end retail. That drives rent costs higher than a medical office in a traditional medical corridor.
Rent should be 8-12% of revenue. I see med spas at 15-18%, usually because the practice signed a lease for a premium location before revenue justified it, or because revenue has not grown to match the space.
If you are at 15% or above, either your revenue needs to grow into the space or the space was the wrong choice. Rent is the hardest cost to fix because leases are long and breaking them is expensive. This is why the financial modeling needs to happen before you sign, not after.
Membership models: stabilizing the revenue
The med spas with the most stable finances run membership programs. A typical model charges $150-$300 per month and includes a set amount of services (usually Botox or filler credits) plus discounts on additional treatments.
A practice with 200 members at $200 per month has $40,000 in predictable monthly revenue before anyone walks through the door. That is $480,000 per year in baseline revenue that does not depend on marketing spend or seasonal demand.
But the pricing has to be right. If your membership gives away too much value, you are discounting profitable services for the appearance of recurring revenue. I have seen memberships where the included services cost the practice more than the membership fee when you account for product cost and provider time.
The math is not hard, but you have to do it. What is the product cost of the included services? What is the staff time cost? What is the total cost per member per month? If the membership fee does not exceed that cost by at least 25-30%, the program is a loss leader with no plan to convert members to higher-value services.
Cash vs insurance: the strategic question
Most med spas operate primarily on a cash-pay basis. Cosmetic services are not covered by insurance. This is a significant advantage because you avoid the entire insurance billing and collections apparatus, and you get paid at the time of service.
But some med spas also offer medical dermatology services that are insurance-billable. Acne treatment, rosacea, skin cancer screenings. These services bring in patients who might convert to cosmetic services, and they add a revenue stream that is less sensitive to economic cycles.
The trade-off: insurance-billable services have lower margins, slower payment, and require billing infrastructure. A med spa doing $2M, all cash-pay, might have a simpler business than one doing $2M with a 70/30 cash-to-insurance split. But the mixed model is more resilient when consumer spending tightens.
If you are considering adding a medical derm component, model it carefully. The revenue per visit will be lower. The billing costs will add overhead. The question is whether the patient acquisition benefit and revenue stability justify those costs.
What good med spa financials look like
Here is a rough benchmark for a well-run med spa doing $2M in revenue:
| Category | Target (% of total revenue) | On $2M Revenue |
|---|---|---|
| Injectable & product COGS | 25-30% | $500K-$600K |
| Staff (all) | 22-28% | $440K-$560K |
| Rent | 8-10% | $160K-$200K |
| Marketing | 8-10% | $160K-$200K |
| Equipment leases | 4-6% | $80K-$120K |
| Supplies (non-injectable) | 2-3% | $40K-$60K |
| All other overhead | 3-5% | $60K-$100K |
| Net margin | 15-25% | $300K-$500K |
These are independent targets per category. A well-run practice operating near the low end of each cost line can achieve margins of 30%+. The table shows realistic ranges, not aspirational floor-to-ceiling targets.
If your net margin is below 20%, one or more of these categories is out of line. The most common culprits are injectable waste, equipment leases on underutilized devices, and marketing spend that is not tracked to patient acquisition.
If you own a med spa and have never seen your costs broken down this way, take the free assessment. We will show you exactly where your margins are going and what is fixable.



